From April 4-5, 2012, delegates will gather at the Marriott Bethesda North Hotel in Bethesda, Maryland for the two day ICH Q3D Metal Impurities Workshop that will feature a program focused on the new limits for element impurities in drug products and how they may impact businesses in the pharma industry.
On Wednesday, April 4th at 9am, SAFC Quality Assurance Director, Patty Benson, will participate in a panel titled “Perspectives From Active Pharmaceutical Ingredient (API) Suppliers”, along with a lineup of speakers from industry colleagues, the IPEC-Americas, CHPA and SOCMA’s Bulk Pharmaceutical Task Force (BPTF) to discuss the draft guidelines and implications data will have, as well as the impact on pharmaceuticals. Patty’s input from an API maker’s perspective will be complemented with an excipient user perspective from Janeen Skutnik-Wilkinson, Director of Quality and Regulatory Policy at Pfizer Inc. and an excipient maker perspective from David Schoneker, Director of Global Regulatory Affairs at Colorcon.
We hope to see you there to learn, network and exchange information amongst industry peers. To learn more about registration for the event, please click here. To learn more about SAFC, please click here.
